Analysts rated Walgreens Boots Alliance, Inc. (NASDAQ:WBA) as Strong Buy

Mutual of America Capital Management LLC boosted its position in Walgreens Boots Alliance Inc. The institutional investor owned 88,933 shares of the pharmacy operator’s stock after selling 141 shares during the period.Walgreens Boots Alliance, Inc.is a holding company.A number of other large investors have also recently modified their holdings of WBA.While looking at the Stock’s Performance, Walgreens Boots Alliance, Inc. now shows a Weekly Performance of -2.76%, where Monthly Performance is -2.4%, Quarterly performance is 5.88%, 6 Months performance is 1.17% and yearly performance percentage is -1.57%.10/21/2016 – Walgreens Boots Alliance, Inc. had its “equal weight” rating reiterated by analysts at Barclays. The original version of this news story can be accessed at https://sportsperspectives.com/2016/12/29/walgreens-boots-alliance-inc-wba-stake-raised-by-cypress-asset-management-inc-tx/.Following Earnings result, share price were UP 3 times out of last 6 Qtrs.07/06/2016 – Walgreens Boots Alliance, Inc. had its “buy” rating reiterated by analysts at Evercore ISI. According to their observations and findings, the stock could provide a high EPS of $1.15/share and a Low EPS of $1.01/share.During last one month it showed the change of -2.40%.The growth estimate for Walgreens Boots Alliance, Inc. (NASDAQ:WBA) traded down 0.86% during mid-day trading on Friday, reaching $82.76.With the amassed value of the company based on its existing stock price alongside the total amount of outstanding stocks, today’s market cap for Air Products and Chemicals, Inc.is valued at 31306.63. The company’s stock is moving with the distance from SMA 50 of 0.24 Percent while the distance from 200-day simple moving average for the stock is 2.92 percent.Marriott International, Inc.’s Average Earnings Estimate for the current quarter is $0.83, according to consensus of 15 analysts. The business earned $28.60 billion during the quarter, compared to analyst estimates of $29.06 billion. Walgreens Boots Alliance had a net margin of 3.56% and a return on equity of 16.33%. The business’s revenue for the quarter was up.4% compared to the same quarter past year. There were earnings of $1.07 per share. (NASDAQ:WBA) shares now have a mean rating of 2.00 while 11 analysts have recommended the shares as “BUY”, 7 commented as “OUTPERFORM” and 7 commented as “HOLD”. Investors of record on Thursday, November 17th were issued a $0.375 dividend. This represents a $1.50 annualized dividend and a yield of 1.81%. Meanwhile, EVP, Chief Commercial Officer Murphy Ken sold 102,172 shares worth $8503000.78, through a transaction dated 2016-11-18. Walgreens Boots Alliance’s payout ratio is 39.27%.TRADEMARK VIOLATION NOTICE: This story was first reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this piece on another website, it was illegally copied and republished in violation of global trademark and copyright legislation. “(WBA)” was originally reported by The Cerbat Gem and is the propert of of The Cerbat Gem.01/07/2016 – Walgreens Boots Alliance, Inc. had its “buy” rating reiterated by analysts at Guggenheim. Deutsche Bank AG restated a “buy” rating and issued a $94.00 target price on shares of Walgreens Boots Alliance in a research report on Friday, September 9th. Finally, Leerink Swann reaffirmed an “outperform” rating and issued a $95.00 price objective on shares of Walgreens Boots Alliance in a research note on Monday, September 19th. Jefferies Group set a $95.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a report on Sunday, October 23rd. The total volume of shares traded was below their three months average volume of 26,240,000 shares. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director William C. Foote sold 2,067 shares of the stock in a transaction that occurred on Wednesday, November 2nd. The firm exchanged hands at a volume of 3,969,703 whereas, the average volume was 4.30M shares. The disclosure for this sale can be found here.10/06/2016 – UBS began new coverage on Walgreens Boots Alliance, Inc. giving the company a “buy” rating. The Company is a pharmacy-led health and wellbeing company.Walgreens Boots Alliance, Inc. operates as a retail drugstore chain.

sport

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>